An interventional study of General Aneasthesia in Patients Underwent Elective Open Inguinal Hernia Surgery Under Spinal Anesthesia and Postoperative Analgesia in Inguinal Hernia Surgery, sponsored by Gaziosmanpasa Research and Education Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Gaziosmanpasa Research and Education Hospital · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 77 studies in Hernia, Inguinal with a site in Turkey — 12 open to participants now, 14 under way, none of them phase 3. Hernia, Inguinal · Turkey.
Among the 77 studies in Hernia, Inguinal with a site in Turkey, this one is the 8th largest by enrollment of the 60 interventional ones that give a count, is one of 8 that started in 2023, is one of 52 with no phase, and was the 77th registered.
545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.
Browse Hernia, Inguinal studies →12 of the 77 studies in Hernia, Inguinal with a site in Turkey are open now. Recruiting first, the newest first:
Hitit University · Sites in Turkey
Medipol University · Sites in Turkey
Ages 18–75
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Haseki Training and Research Hospital · Sites in Turkey
Ages 18+
Nigde Omer Halisdemir University · Sites in Turkey
Ages 18–75
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
77 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 8 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 124 is above the median of 90 across 397 interventional studies indexed under Hernia, Inguinal.
Median enrollment 80 across the 60 interventional studies, 63 across the 17 observational. Of the 53 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 77 has an industry lead sponsor. The 10 most frequent:
Gaziosmanpasa Research and Education Hospital is the lead sponsor of 128 studies on the registry; 27 are open to participants now.
Gaziosmanpasa Research and Education Hospital has 3 studies filed under Hernia, Inguinal — fewer than ten, so there is no comparison to draw.
3 of the studies in Hernia, Inguinal with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07612839Hakan EmirkadıIntravenous Lidocaine for Postoperative Fatigue After Laparoscopic TAPP Inguinal Hernia Repair | 2026-12-31 |
| NCT07891845Hitit UniversityComparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair | 2027-01-01 |
| NCT07604259Medipol UniversityComparison of QLB and TFP Block for Postoperative Analgesia in Laparoscopic Inguinal Hernia | 2027-04-10 |
Add all 3 to your calendar (.ics) → With an account.
Among the 77 studies in Hernia, Inguinal with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective, randomized, single-blind clinical trial evaluated the postoperative analgesic efficacy of anterior quadratus lumborum block, posterior quadratus lumborum block, and paravertebral block in patients undergoing elective open inguinal hernia surgery under spinal anesthesia.
A total of 124 patients were included and allocated to four groups: control, anterior quadratus lumborum block, posterior quadratus lumborum block, and paravertebral block.
The primary outcome was total analgesic consumption during the first 24 postoperative hours. Secondary outcomes included the requirement for rescue analgesia, time to first rescue analgesic administration, postoperative pain scores at rest and during movement, and postoperative nausea and vomiting.
Patients undergoing elective open inguinal hernia repair under spinal anesthesia were included in this prospective randomized clinical trial.
Standard monitoring included electrocardiography, non-invasive blood pressure measurement, and peripheral oxygen saturation. Spinal anesthesia was performed at the L3-L4 or L4-L5 intervertebral space using a 25-gauge spinal needle, with 12-14 mg intrathecal bupivacaine.
At the end of surgery, patients received intravenous dexketoprofen 50 mg. Participants were subsequently allocated to one of four study groups.
Patients in the anterior quadratus lumborum block group received an ultrasound-guided unilateral anterior/transmuscular quadratus lumborum block with 20 mL of 0.25% bupivacaine.
Patients in the posterior quadratus lumborum block group received an ultrasound-guided unilateral posterior quadratus lumborum block with 20 mL of 0.25% bupivacaine.
Patients in the paravertebral block group received an ultrasound-guided unilateral thoracic paravertebral block with 20 mL of 0.25% bupivacaine.
Patients in the control group did not receive an additional regional block. Postoperatively, patients received intravenous paracetamol 1 g four times daily. Rescue analgesia was administered when the postoperative pain score was ≥4 according to the study analgesia protocol.
Postoperative assessments were performed at 1, 4, 8, 12, and 24 hours.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age between 18 and 65 years
Exclusion Criteria:
Patient refusal to participate
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Following surgery, an ultrasound-guided unilateral anterior/transmuscular quadratus lumborum block was performed. A total of 20 mL of 0.25% bupivacaine was administered into the fascial plane between the quadratus lumborum and psoas major muscles.
Procedure: General Aneasthesia
Following surgery, an ultrasound-guided unilateral posterior quadratus lumborum block was performed. A total of 20 mL of 0.25% bupivacaine was administered at the posterior border of the quadratus lumborum muscle.
Procedure: General Aneasthesia
Following surgery, an ultrasound-guided unilateral thoracic paravertebral block was performed at the T10-T11 level using 20 mL of 0.25% bupivacaine.
Procedure: General Aneasthesia
general anesthesia
Total Postoperative Analgesic Consumption During the First 24 Hours
Total rescue analgesic consumption during the first 24 hours after surgery was recorded for each participant.
Time frame: 0-24 hours after surgery
Requirement for Rescue Analgesia
The number and proportion of participants requiring rescue analgesic medication during the first 24 postoperative hours were recorded.
Time frame: 0-24 hours after surgery
Time to First Rescue Analgesic Administration
The time from completion of surgery/intervention to the first administration of rescue analgesia was recorded.
Time frame: Up to 24 hours after surgery
Plan to share: Yes
No publications or documents are linked to this record.
Ran from Mar 2023 to primary completion in Sep 2023, 6 months.
Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 6 months is below that.
Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gaziosmanpasa Research and Education Hospital →